Compare Ascendis Pharma A/S (ASND) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Kimberly Clark Corp — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Kimberly Clark Corp trades at $108.02 (market cap $36.11B). The key difference: Kimberly Clark Corp is far larger — about 2.2× Ascendis Pharma A/S's market cap, and Kimberly Clark Corp pays a 4.72% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | KMB | |
|---|---|---|
Market Cap | $16.67B | $36.11B |
Sector | Health | Consumer Staples |
52-Week High | $277.18 | $134.81 |
52-Week Low | $189.74 | $93.05 |
Enterprise Value | $17.04B | $41.67B |
Dividend Yield | — | 4.72% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
